claimdepot.com

Twist Bioscience $17M Securities Class Action Settlement Claim Process

Twist Bioscience logoTwist Bioscience
Sig3.65Sen-4.30Env0.00Soc0.00Gov-3.90

Investors who bought Twist Bioscience shares tied to the December 2020 offering at $110 per share, or between Dec. 20, 2018 and Nov. 15, 2022, can submit a claim for cash under a securities class action settlement. Recognized losses exclude short sales and use set formulas, including 10% of $110 minus the sale price for early sold shares, $16.37 per share for Aug. 7, 2026 holdings, or the lesser of $8.11 and purchase minus $25.98 for Feb. 10, 2023.

Coverage (1)

ABOUT

What is Fimmer?

Most feeds treat all company headlines the same. An executive interview, an office closure, stock analysis, and a data breach can sit side by side with no sense of scale. Fimmer ranks coverage by what matters, so important events stand out and signals are prioritised over noise. We cluster related company news and score each story using a range of metrics, so you see the most crucial stories first.

SCORING

What do the scores mean?

Significance (0–10) measures the scale of the real-world impact. Sentiment and ESG (−10 to +10) indicate the tone of the coverage and whether the change relates to environmental, social, or governance factors. Together, these scores help distinguish meaningful developments from routine company news. More information about our scoring methodology can be found on our About page.

DISCOVERY

Explore more on Fimmer

Search more than 10,000 public companies, browse the company index, explore their scores, and read the coverage behind them, with our core features available to everyone for free.

For more advanced features, Pro gives you access to dynamic feeds, custom sorting, and more ways to track the companies that matter to you.

More with Pro